Research Article: Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy
Introduction:
Telomerase, an enzyme that exists in the human body, is not well expressed in normal cells; however, it is overexpressed in most cancer cells. Tumor cells protect the telomere that exists at the end of the DNA so that they do not undergo apoptosis due to aging and divide beyond the normal cell division frequency, extending the lifespan of the cell. Tertomotide is a telomerase-based peptide that kills cancer cells via the autoimmune system and has been developed to treat patients with cancer. It is an immune…
Read more